InnoCellular is honored to support EVANTICA and excited to participate in the upcoming symposium, co-organized by A*STAR – Agency for Science, Technology and Research and National University of Singapore on July 4th, from 10AM to 1:30PM!
🎗️ The EVANTICA program is dedicated to developing a highly efficient, specific and scalable drug delivery platform using Extracellular vesicles (EV), derived from Mesenchymal Stem Cells for Anti-Cancer Therapy.
🔬 Featured speakers include,
Prof. Harvey Lodish from Massachusetts Institute of Technology Whitehead Institute
Prof. Jonathan Loh from The Cell Fate Engineering and Therapeutics Laboratory Institute of Molecular and Cell Biology (IMCB)
Dr. Minh Le from National University of Singapore
Prof. Qi-Jing Li from Institute of Molecular and Cell Biology (IMCB)
🤝 It’s a fantastic opportunity for us to engage with leaders, innovators, and fellow professionals in this cutting-edge field. See you at the event!